Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Why the Orionid Meteor Shower 2025 still matters even after its peak night has passed The Orionid Meteor Shower 2025 continues post-peak. Discover its Halley's Comet origins, global visibility, and why this sky event still matters. byVenkateshNovember 2, 2025